Last $1.10 USD
Change Today +0.01 / 0.92%
Volume 16.4K
ARQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 10:12 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian Schwartz M.D.

Chief Medical Officer and Senior Vice President of Clinical & Regulatory Affairs, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

52$663,919
As of Fiscal Year 2013

Background*

Dr. Brian Schwartz, MD has been the Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs at ArQule Inc. since July 14, 2008. Dr. Schwartz served as Senior Vice President of Medical & Regulatory Affairs and Chief Medical Officer of Ziopharm Oncology, Inc. from June 1, 2006 to July 11, 2008. He has extensive regulatory experience in working with the U.S. Food and Drug Administration Oncology Division, the European Medicines Evaluation Agency, ...

Read Full Background

Corporate Headquarters*

19 Presidential Way
Woburn, Massachusetts 01801

United States

Phone: 781-994-0300
Fax: 781-376-6019

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
University of Pretoria

Other Affiliations*

Annual Compensation*

Salary$380,258
Total Annual Compensation$380,258

Stock Options*

All Other Compensation$8,100
Exercisable Options364,875
Unexercisable Options260,125
Total Number of Options625,000

Total Compensation*

Total Annual Cash Compensation$517,936
Total Short Term Compensation$380,258
Other Long Term Compensation$8,100
Total Calculated Compensation$663,919
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARQL:US $1.10 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Tuan Ha-Ngoc Chief Executive Officer, President and Director
AVEO Pharmaceuticals, Inc.
$567.9K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.